Analyst Ratings for Enanta Pharmaceuticals (ENTA) [Neutrals]
ENTA Rating Summary
ENTA Price Target Summary
- Highest: $28.00 (H.C. Wainwright)
- Lowest: $11.00 (JPMorgan)
- Average: $19.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.71 (+52.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Avg. $ Target:
$19.71 (+52.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2023 | Jefferies | Akash Tewari | Downgrade | Hold (Buy) |
18.00 (49.00) |
19.82 (12.92) |
-34.81% | Details |
| 9/9/2021 | Leerink Partners » Updated 5/19/2022 |
Roanna Ruiz | New Coverage | Market Perform (N/A) |
44.00 (58.00) |
57.17 (12.92) |
-77.4% | Details |
 |
||||||||
|
||||||||
